Ascentage Pharma Group International
Ascentage Pharma Group International (AAPG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AAPG · as of Jun 8, 2026
Key Statistics
Explore Ascentage Pharma Group International Data
aapg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The AAPG analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $40.00, representing +132.56% upside from the current price of $17.20.
Competitors & Peers
aapg competitorsAAPG
APGE
CELC
CGON
CNTA
IRONStock Performance
Full HistoryAbout Ascentage Pharma Group International
Ascentage Pharma Group International a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's…
what is ascentage pharma group international · aapg stock overview · ascentage pharma group international company profile · who is ascentage pharma group international ceo · aapg NASDAQ · ascentage pharma group international headquarters · ascentage pharma group international business segments
About Stock Overview & Key Data
Ascentage Pharma Group International (AAPG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 24, 2025. As of the latest trading session, AAPG stock price is $17.20, with a market capitalization of $1.6B. The stock has returned -42.44% over the past 12 months and -34.45% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Ascentage Pharma Group International stock is Buy, with an average 12-month price target of $40.00. In fiscal year 2025, Ascentage Pharma Group International reported revenue of $558.5M and net income of -$1.2B. For detailed data — including Ascentage Pharma Group International revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ascentage Pharma Group International (AAPG) stock price is $17.20. The stock is traded on NASDAQ under the ticker symbol AAPG. The 52-week range is $17.10 – $48.45.